Article
Serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant v5 (sCD44-v5), and CD44 splice variant v6 (sCD44-v6) in patients with epithelial ovarian cancer.
Anticancer research - 1 Jan 2000
Gadducci A, Ferdeghini M, Fanucchi A, Annicchiarico C, Cosio S, Prontera C, Bianchi R, Genazzani A R
Abstract excerpt
Different variants of the cell adhesion molecule CD44 have been involved in malignant transformation and cancer metastasis. In the present investigation we assessed the preoperative serum levels of soluble CD44 standard (sCD44-st), sCD44 splice variant 5 (sCD44-v5), and sCD44 splice variant 6 (sCD44-v6) in 51 patients with ovarian cancer. Median preoperative sCD44-st, sCD44v5, and sCD44-v6 levels were 417 ng/ml...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.